Your browser doesn't support javascript.
loading
First-line FOLFIRI and bevacizumab in patients with advanced colorectal cancer prospectively stratified according to serum LDH: final results of the GISCAD (Italian Group for the Study of Digestive Tract Cancers) CENTRAL (ColorEctalavastiNTRiAlLdh) trial.
Giampieri, Riccardo; Puzzoni, Marco; Daniele, Bruno; Ferrari, Daris; Lonardi, Sara; Zaniboni, Alberto; Cavanna, Luigi; Rosati, Gerardo; Pella, Nicoletta; Zampino, Maria Giulia; Sozzi, Pietro; Germano, Domenico; Zagonel, Vittorina; Codecà, Carla; Libertini, Michela; Labianca, Roberto; Cascinu, Stefano; Scartozzi, Mario.
Afiliação
  • Giampieri R; Department of Medical Oncology Unit, University Hospital and Università Politecnica delle Marche, Ancona, Italy.
  • Puzzoni M; Department of Medical Oncology Unit, University Hospital and University of Cagliari, Cagliari, Italy.
  • Daniele B; Department of Medical Oncology Unit, Ospedale G. Rummo, Benevento, Italy.
  • Ferrari D; Department of Medical Oncology Unit, Azienda Ospedaliera San Paolo, Milano, Italy.
  • Lonardi S; Department of Medical Oncology Unit 1, Istituto Oncologico Veneto-IRCCS, Padova, Italy.
  • Zaniboni A; Department of Medical Oncology Unit, Fondazione Poliambulanza, Brescia, Italy.
  • Cavanna L; Department of Medical Oncology Unit, Ospedale di Piacenza, Piacenza, Italy.
  • Rosati G; Department of Medical Oncology Unit, Ospedale San Carlo, Potenza, Italy.
  • Pella N; Department of Medical Oncology Unit, Azienda Ospedaliero Universitaria Santa Maria della Misericordia, Udine, Italy.
  • Zampino MG; Department of Gastrointestinal Medical Oncology Unit and Neuroendocrine Tumors, Istituto Europeo di Oncologia-IRCCS, Milano, Italy.
  • Sozzi P; Department of Medical Oncology Unit, Nuovo Ospedale degli Infermi, Biella, Italy.
  • Germano D; Department of Medical Oncology Unit, Ospedale G. Rummo, Benevento, Italy.
  • Zagonel V; Department of Medical Oncology Unit 1, Istituto Oncologico Veneto-IRCCS, Padova, Italy.
  • Codecà C; Department of Medical Oncology Unit, Azienda Ospedaliera San Paolo, Milano, Italy.
  • Libertini M; Department of Medical Oncology Unit, Fondazione Poliambulanza, Brescia, Italy.
  • Labianca R; Department of Medical Oncology Unit, ASST Papa Giovanni XXIII, Bergamo, Italy.
  • Cascinu S; Department of Modena Cancer Center, Università di Modena e Reggio Emilia, Modena, Italy.
Br J Cancer ; 117(8): 1099-1104, 2017 Oct 10.
Article em En | MEDLINE | ID: mdl-28926529
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Camptotecina / Neoplasias Colorretais / Protocolos de Quimioterapia Combinada Antineoplásica / Inibidores da Angiogênese / Bevacizumab Tipo de estudo: Observational_studies / Prognostic_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Br J Cancer Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Itália
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Camptotecina / Neoplasias Colorretais / Protocolos de Quimioterapia Combinada Antineoplásica / Inibidores da Angiogênese / Bevacizumab Tipo de estudo: Observational_studies / Prognostic_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Br J Cancer Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Itália